U.S. Mortgage Finance Stock News

Acuity Brands (AYI) has just opened Q1 2026 earnings season with context of recent quarterly revenue of US$1.2b and basic EPS of US$3.71, alongside trailing twelve month EPS of US$12.85 on revenue of US$4.3b. Over the past few quarters, the company has seen revenue move from US$968.1m in Q3 2024 to US$1.2b in Q4 2025, while quarterly basic EPS has ranged from US$2.50 to US$3.86 across that stretch. This sets the backdrop for how you might frame the latest print. With trailing net profit...

Richardson Electronics (RELL) just posted its latest quarter with Q2 2026 revenue of US$54.6 million and basic EPS of US$0.13, while trailing 12 month figures sit at US$209.8 million of revenue and EPS of US$0.01. Over recent quarters the company has seen revenue move between US$47.4 million and US$54.6 million, with basic EPS ranging from a quarterly loss of US$0.14 to a profit of US$0.13. This feeds into a trailing year that includes one large US$2.8 million loss item and only a small net...

Abbott Laboratories (ABT) just introduced Libre Assist within its Libre app at CES 2026, using generative AI and continuous glucose data to give diabetes patients real time guidance on how upcoming meals might affect their glucose levels. See our latest analysis for Abbott Laboratories. The Libre Assist launch comes as Abbott’s share price sits at US$126.18, with a 30 day share price return of 4.07% and some recent volatility reflected in a 90 day share price return of a 4.82% decline, while...

Moog (MOG.A) is back on many investors’ screens after a series of earnings surprises over the last four quarters. This has aligned with stronger sentiment and fresh debate around what the stock is worth. See our latest analysis for Moog. Recent enthusiasm has also shown up in the trading data, with a 12.18% 30 day share price return and a 30.45% 1 year total shareholder return. This points to building momentum around Moog at the current US$262.98 share price. If Moog has caught your...

Globus Medical (GMED) is back in focus after management issued new guidance that points to fourth quarter 2025 sales of about US$823.2 million and full year 2025 revenue of roughly US$2.936b. See our latest analysis for Globus Medical. The guidance update has arrived after a strong run in the shares, with a 90-day share price return of 67.26% and a 1-year total shareholder return of 9.32%. This suggests that momentum has recently picked up from a more modest long term profile. If this kind of...

Applied Digital (APLD) reported Q2 2026 revenue of US$126.6 million with a basic EPS loss of US$0.11, alongside earnings from discontinued operations of US$12.1 million and net income excluding extra items showing a loss of US$31.2 million. Over the past three quarters, the company has seen revenue move from US$38.0 million in Q4 2025 to US$64.2 million in Q1 2026 and then to US$126.6 million in Q2 2026. Over the same period, basic EPS moved from a loss of US$0.12 in Q4 2025 to a loss of...

Earlier this week at CES 2026, Garmin unveiled its Unified Cabin 2026 automotive platform with an AI/LLM-based virtual assistant, expanded its Qualcomm-powered Nexus high-performance compute collaboration, and introduced new trucking camera and JL Audio AP Amplifier products for marine and off-road vehicles. Together, these launches highlight Garmin’s push deeper into software-rich automotive and connected audio systems, positioning its hardware as part of broader, integrated in-cabin and...

Simply Good Foods (SMPL) has just opened its 2026 financial year with Q1 results that cap a choppy run of quarterly earnings, moving from Basic EPS of US$0.41 and US$0.36 in Q3 and Q2 2025 to a loss of US$0.12 in Q4 2025, on quarterly revenue that moved between US$341.3 million and US$381.0 million over that 2025 span. Over the same period, trailing 12 month revenue ranged from about US$1.33 billion to US$1.46 billion, while trailing EPS moved between US$1.03 and US$1.47. Taken together, this...

Why Albertsons Companies Stock Is On Investors’ Radar Albertsons Companies (ACI) has drawn fresh attention after recent share price moves, with the stock closing at $16.63 as investors reassess its position in the competitive US food and drug retail sector. See our latest analysis for Albertsons Companies. The latest 3.4% 1 day share price return contrasts with weaker recent momentum, including a 3.5% 30 day share price return and a 13.8% 1 year total shareholder return. This suggests...

PACS Group recently attracted supportive analyst coverage highlighting its revenue growth, stronger internal controls after an audit, and a renewed focus on healthcare services expansion. At the same time, the company has reinforced its leadership with new Chief Compliance Officer and Chief Human Resources Officer appointments, underlining a stronger governance and culture framework. Next, we will examine how this combination of enhanced management oversight and analyst confidence shapes...

CBRE Group stock update CBRE Group (CBRE) has attracted fresh attention after recent share price moves, with the stock showing a 0.2% decline over the past day but gains over the past week and month. See our latest analysis for CBRE Group. The recent 7 day share price return of 3.2% and 30 day return of 6.4% sit within a broader picture where the year to date share price return is 3.6%. The 1 year total shareholder return of 27.9% and 5 year total shareholder return of 166.6% point to strong...

FDA clinical hold and new patent shift Erasca’s risk profile The key trigger for Erasca (ERAS) was the FDA’s partial clinical hold on its Phase 1 BOREALIS-1 trial for ERAS-4001, paired with fresh patent protection for its pan-RAS molecular glue ERAS-0015. See our latest analysis for Erasca. After a sharp pre-market drop on the clinical hold news, Erasca’s recent catalyst mix, including the ERAS-0015 patent and competitor data in pan-KRAS, has coincided with a 90-day share price return of...

Hamilton Lane (HLNE) is back on investors’ radar after emerging as a balance sheet partner in Pluto Financial Technologies’ new AI-powered lending platform for private markets. This move directly connects the firm to private-asset credit growth. See our latest analysis for Hamilton Lane. The Pluto partnership lands at a time when momentum in Hamilton Lane's shares has been picking up. The 7 day share price return is 9.22% and the 90 day share price return is 24.05% from a latest share price...

Construction milestone and geopolitical interest put Critical Metals in focus Critical Metals (CRML) has formally approved and begun construction of an Arctic-grade, multi-use storage and pilot-plant facility in Qaqortoq, Greenland, a key step for advancing its Tanbreez rare earths project. The company is also setting up a permanent local office in Qaqortoq. Its shares have recently moved sharply, helped by investor attention on Western access to rare earth supply chains and Greenland’s...

Why Buckle stock is back in focus Buckle (BKE) is on investors’ radar after reporting a 5.5% rise in comparable store net sales and 6.5% growth in total net sales for the 5 week period ending January 3, 2026. See our latest analysis for Buckle. The latest sales update comes as Buckle’s share price sits at US$55.61, with a 1 day share price return of 3.19% and a 90 day share price return of 5.46%, while the 1 year total shareholder return of 19.90% and 5 year total shareholder return of...

What recent returns say about Luckin Coffee Luckin Coffee (OTCPK:LKNC.Y) has drawn attention after a mixed stretch for shareholders, with the stock showing a 0.6% gain over the past day and 1.2% over the past week, but negative returns over the past month and past 3 months. See our latest analysis for Luckin Coffee. That recent 1-day and 7-day share price strength comes after a weaker stretch, with a 30-day share price return of 10.1% and a 90-day share price return of 14.2%. The 1-year total...

Serve Robotics (SERV) is back in focus after passing its 2025 goal early by deploying more than 2,000 autonomous delivery robots across U.S. cities and expanding into Fort Lauderdale, alongside fresh analyst coverage and easing short interest. See our latest analysis for Serve Robotics. The recent deployment milestone and fresh analyst coverage have come alongside strong near term momentum, with a 1 day share price return of 14.40% and a 7 day share price return of 48.46% at a latest share...

Silicon Motion Technology (SIMO) is back in focus after iKKO, MediaTek, and SIMO jointly unveiled MindOne, a card sized AI smartphone built around always on AI connectivity, along with fresh visibility from recent investor conferences. See our latest analysis for Silicon Motion Technology. Those AI connectivity headlines and a busy investor conference schedule have arrived alongside a strong run in the shares, with a 7 day share price return of 19.77% and a 1 year total shareholder return of...

In the past quarter, Origin Bancorp (NYSE: OBK) reported third-quarter results with revenue rising 11.5% year on year and earnings per share coming in above analyst forecasts. This outperformance relative to expectations, alongside generally satisfactory results across regional banks, points to resilient operations and sector-wide support for Origin’s performance. With Origin’s third-quarter revenue and earnings surpassing expectations, we’ll now examine how this performance may influence...

If you are wondering whether Mirum Pharmaceuticals' share price still offers value at around US$81.98, it helps to step back and look at what the current market price is really implying. The stock has delivered returns of 3.8% over the last 7 days, 20.7% over the last 30 days, 5.0% year to date and 95.2% over the last year, with a multi year return of 293.6% across three years and 320.8% across five years. These figures may catch the eye of growth focused investors. Recent share price moves...

Recent commentary around StepStone Group (STEP) focuses on its strong compound growth in revenue and earnings, along with gains in assets under management. This has renewed investor interest and raised fresh questions about how to view the stock now. See our latest analysis for StepStone Group. StepStone Group's recent commentary on revenue and earnings growth has been backed by strong price momentum, with a 10.74% 7 day share price return and a 12.96% 90 day share price return, while the 3...

In recent days, BD (Becton, Dickinson and Company) reported the first European prophylactic laparotomy reinforcement case in Greece using its Phasix™ Mesh, following expanded CE-marked approval, new product sizes, and broader availability across Europe and the U.K. for hernia prophylaxis indications. This broader European indication, supported by ongoing PREVENT trial enrollment, points to a potentially wider clinical role for bioabsorbable mesh in high‑risk abdominal surgeries and...

Disc Medicine (IRON) has attracted investors’ attention after submitting a New Drug Application for bitopertin aimed at accelerated FDA review, alongside Phase 2 results for DISC-0974 that suggest broader use with existing JAK inhibitor therapies. See our latest analysis for Disc Medicine. The share price has moved to $80.94 after a 4.63% 1 day share price return. However, the 30 day share price return of a 12.25% decline contrasts with a 14.40% 90 day share price return and a very large 3...

If you are wondering whether First Solar's recent share price justifies the current valuation, you are not alone. This article is built to help you frame that question clearly. The stock last closed at US$246.26, with returns of 28.8% over 1 year, 37.7% over 3 years and 132.2% over 5 years. The year-to-date return of a 10.2% decline and recent 7-day and 30-day returns of 5.7% and 2.8% declines hint at shifting expectations. Recent news coverage of First Solar has focused on its position as a...